(Reuters) – A panel of independent advisers to the U.S. Food and Drug Administration is set to meet on April 6 to discuss considerations for use of COVID-19 vaccine booster doses from Pfizer Inc and Moderna Inc.
The panel will also discuss the process for selecting COVID-19 vaccine strain to address current and emerging variants, the U.S. FDA said.
(Reporting by Manojna Maddipatla and Leroy Leo in Bengaluru; Editing by Devika Syamnath)
